GeoVax Labs, Inc.
GOVX
$0.51
-$0.01-1.35%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -69.01% | 827.67% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -69.01% | 827.67% | |||
| Cost of Revenue | 2.77% | 73.09% | |||
| Gross Profit | -46.18% | -16.03% | |||
| SG&A Expenses | 28.96% | 14.29% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 6.53% | 61.18% | |||
| Operating Income | -42.53% | -15.65% | |||
| Income Before Tax | -42.08% | -14.84% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -42.08% | -14.84% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -42.08% | -14.84% | |||
| EBIT | -42.53% | -15.65% | |||
| EBITDA | -42.90% | -15.59% | |||
| EPS Basic | 5.65% | 54.46% | |||
| Normalized Basic EPS | 5.66% | 54.46% | |||
| EPS Diluted | 5.65% | 54.46% | |||
| Normalized Diluted EPS | 5.66% | 54.46% | |||
| Average Basic Shares Outstanding | 50.59% | 152.17% | |||
| Average Diluted Shares Outstanding | 50.59% | 152.17% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||